7-117611751-G-T

Variant names:

• chr7-117611751-G-T
• rs397508538
• NM_000492.4:c.3310G>T

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1 PM2 PP5_Very_Strong

The NM_000492.4(CFTR):​c.3310G>T​(p.Glu1104*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★★). Variant results in nonsense mediated mRNA decay.

• Frequency: Genomes: not found (cov: 31)
• Consequence: CFTR NM_000492.4 stop_gained
• Clinical Significance: Pathogenic reviewed by expert panel P:8
• Conservation: PhyloP100: 9.89
• Publications: 22 publications found

Genes affected

CFTR (HGNC:1884): (CF transmembrane conductance regulator) This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017]

CFTR Gene-Disease associations (from GenCC):

• cystic fibrosis

  Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Orphanet
• congenital bilateral absence of vas deferens

  Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
• hereditary chronic pancreatitis

  Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

ENSG00000083622 (HGNC:40145):

ACMG classification

Our verdict: Pathogenic. The variant received 18 ACMG points.

• PVS1: Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
• PM2: Very rare variant in population databases, with high coverage
• PP5: Variant 7-117611751-G-T is Pathogenic according to our data. Variant chr7-117611751-G-T is described in CliVar as Pathogenic. Clinvar id is 53715.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr7-117611751-G-T is described in CliVar as Pathogenic. Clinvar id is 53715.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr7-117611751-G-T is described in CliVar as Pathogenic. Clinvar id is 53715.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr7-117611751-G-T is described in CliVar as Pathogenic. Clinvar id is 53715.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr7-117611751-G-T is described in CliVar as Pathogenic. Clinvar id is 53715.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr7-117611751-G-T is described in CliVar as Pathogenic. Clinvar id is 53715.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr7-117611751-G-T is described in CliVar as Pathogenic. Clinvar id is 53715.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr7-117611751-G-T is described in CliVar as Pathogenic. Clinvar id is 53715.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr7-117611751-G-T is described in CliVar as Pathogenic. Clinvar id is 53715.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr7-117611751-G-T is described in CliVar as Pathogenic. Clinvar id is 53715.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr7-117611751-G-T is described in CliVar as Pathogenic. Clinvar id is 53715.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr7-117611751-G-T is described in CliVar as Pathogenic. Clinvar id is 53715.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr7-117611751-G-T is described in CliVar as Pathogenic. Clinvar id is 53715.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr7-117611751-G-T is described in CliVar as Pathogenic. Clinvar id is 53715.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr7-117611751-G-T is described in CliVar as Pathogenic. Clinvar id is 53715.Status of the report is reviewed_by_expert_panel, 3 stars.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
CFTR	NM_000492.4	c.3310G>T	p.Glu1104*	stop_gained	Exon 20 of 27	ENST00000003084.11	NP_000483.3
CFTR-AS2	NR_199597.1	n.177+4478C>A		intron_variant	Intron 2 of 2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
CFTR	ENST00000003084.11	c.3310G>T	p.Glu1104*	stop_gained	Exon 20 of 27	1	NM_000492.4	ENSP00000003084.6

Frequencies

GnomAD3 genomes Cov.: 31

GnomAD4 exome Cov.: 31

GnomAD4 genome Cov.: 31

Alfa AF: 0.00 Hom.: 0

ClinVar

Significance: Pathogenic

Submissions summary: Pathogenic:8

Revision: reviewed by expert panel

Submissions by phenotype

Cystic fibrosis Pathogenic:6

Aug 03, 2017

Counsyl

Significance: Pathogenic

Review Status: no assertion criteria provided

Collection Method: clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

Mar 23, 2023

Ambry Genetics

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The p.E1104* pathogenic mutation (also known as c.3310G>T), located in coding exon 20 of the CFTR gene, results from a G to T substitution at nucleotide position 3310. This changes the amino acid from a glutamic acid to a stop codon within coding exon 20. This alteration has been identified in the homozygous state in multiple individuals diagnosed with cystic fibrosis (Hadj Fredj S et al. Ann Hum Biol, 2011 Sep;38:561-3; Hamouda S et al. Afr Health Sci, 2020 Mar;20:444-452). This variant has been reported in multiple individuals with an elevated sweat chloride level in The Clinical and Functional TRanslation of CFTR (CFTR2) database (available at http://cftr2.org. Accessed 03/23/2023). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -

Aug 25, 2022

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 53715). This premature translational stop signal has been observed in individual(s) with cystic fibrosis (PMID: 7537150, 25481366). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu1104*) in the CFTR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CFTR are known to be pathogenic (PMID: 1695717, 7691345, 9725922). -

Mar 17, 2017

CFTR2

Significance: Pathogenic

Review Status: reviewed by expert panel

Collection Method: research

- -

Jan 29, 2018

CFTR-France

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: curation

- -

Jun 11, 2019

Genome Diagnostics Laboratory, The Hospital for Sick Children

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

CFTR-related disorder Pathogenic:2

Mar 17, 2017

Natera, Inc.

Significance: Pathogenic

Review Status: no assertion criteria provided

Collection Method: clinical testing

- -

Jun 11, 2019

Genome Diagnostics Laboratory, The Hospital for Sick Children

Significance: Pathogenic

Review Status: no assertion criteria provided

Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_addAF	Pathogenic	0.63	D
BayesDel_noAF	Pathogenic	0.66
CADD	Pathogenic	41
DANN	Uncertain	1.0
Eigen	Pathogenic	1.3
Eigen_PC	Pathogenic	1.1
FATHMM_MKL	Pathogenic	0.99	D
PhyloP100		9.9
Vest4		0.87
GERP RS		5.7
PromoterAI		-0.020	Neutral
Mutation Taster		=0/200	disease causing (ClinVar)

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs397508538; hg19: chr7-117251805; COSMIC: COSV50043254;